BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1860832)

  • 1. Comparison of protein synthesis inhibition kinetics and cell killing induced by immunotoxins.
    Sung C; Wilson D; Youle RJ
    J Biol Chem; 1991 Aug; 266(22):14159-62. PubMed ID: 1860832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
    J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant hybrid toxin with dual enzymatic activities. Potential use in preparing highly effective immunotoxins.
    Li BY; Ramakrishnan S
    J Biol Chem; 1994 Jan; 269(4):2652-8. PubMed ID: 8300596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective cytotoxic effect of an immunotoxin on human erythroid tumor cells].
    Tonevitskiĭ AG; Agapov II; Mechetner EB
    Mol Biol (Mosk); 1991; 25(5):1181-7. PubMed ID: 1753950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic comparison of ricin immunotoxins: biricin conjugate has potentiated cytotoxicity.
    Marsh JW; Neville DM
    Biochemistry; 1986 Jul; 25(15):4461-7. PubMed ID: 3489484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity.
    Greenfield L; Johnson VG; Youle RJ
    Science; 1987 Oct; 238(4826):536-9. PubMed ID: 3498987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells.
    Wenning LA; Yazdi PT; Murphy RM
    Biotechnol Bioeng; 1998 Feb; 57(4):484-96. PubMed ID: 10099226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of ricin, diphtheria toxin and alpha-Amanitin for Acanthamoeba castellanii (1983).
    Howell MD; Villemez CL
    J Parasitol; 1984 Dec; 70(6):918-23. PubMed ID: 6527187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
    Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
    Youle RJ; Uckun FM; Vallera DA; Colombatti M
    J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons.
    Riedel CJ; Muraszko KM; Youle RJ
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5051-5. PubMed ID: 2367523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
    Thompson J; Hu H; Scharff J; Neville DM
    J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxins.
    Engert A; Brown A; Thorpe P
    Leuk Res; 1991; 15(11):1079-86. PubMed ID: 1961012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of immunotoxin efficacy by acid-cleavable cross-linking agents utilizing diphtheria toxin and toxin mutants.
    Neville DM; Srinivasachar K; Stone R; Scharff J
    J Biol Chem; 1989 Sep; 264(25):14653-61. PubMed ID: 2475487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
    Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
    Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different behavior of diphtheria toxin, modeccin and ricin in HeLa cells infected with Trypanosoma cruzi.
    Osuna A; Rodriguez-Cabezas N; Gamarro F; Mascaro C
    J Eukaryot Microbiol; 1994; 41(3):231-6. PubMed ID: 8049687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of diphtheria toxin-induced apoptosis in Vero cells by combination treatment with brefeldin A and okadaic acid.
    Kusano I; Kageyama A; Tamura T; Oda T; Muramatsu T
    Cell Struct Funct; 2001 Oct; 26(5):279-88. PubMed ID: 11831360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
    Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
    Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.